Response to Cioffi
J Infect Dis
.
2020 Jun 16;222(1):169-170.
doi: 10.1093/infdis/jiaa217.
Authors
Nir Eyal
1
2
3
,
Marc Lipsitch
4
5
,
Peter G Smith
6
Affiliations
1
Center for Population-Level Bioethics, Rutgers University, New Brunswick, New Jersey, USA.
2
Department of Philosophy, Rutgers University, New Brunswick, New Jersey, USA.
3
Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA.
4
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
5
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
6
MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.
PMID:
32348499
DOI:
10.1093/infdis/jiaa217
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines*
Coronavirus*
Humans
Substances
COVID-19 Vaccines
Grants and funding
MR/R010161/1/MRC_/Medical Research Council/United Kingdom